Phase Labs

In 2024, my master’s thesis on kidney regeneration opened an unexpected door. While mapping how organs heal at the molecular level, I began collaborating with Juan Pablo Ebrath—who is now the CEO of Phase Labs—on an ambitious idea: using transcriptomic data, AI, and machine learning to model regeneration. What started with kidneys soon expanded into the vision of reprogramming morphogenesis across the body—hearts, limbs, and beyond.

I helped co-create the early concept, but later chose to focus my career on renewable energy, while Juan Pablo now leads Phase Labs as the sole driver of this mission. At the crossroads of developmental biology, AI, physics, and engineering, the company continues to reimagine what’s possible for regenerative medicine.